Wcm Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History

Wcm Investment Management, LLC

$36.3 Billion
Q2 2024

A detailed history of Wcm Investment Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Wcm Investment Management, LLC holds 310,829 shares of HALO stock, worth $17.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

310,829

Previous 306,339 1.47%

Holding current value

$17.8 Million

Previous $12.5 Million 30.61%

% of portfolio

0.04%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$37.81 - $52.4 $169,766 - $235,276	4,490 Added 1.47%	310,829 $16.3 Million
Q1 2024 Apr 25, 2024	SELL	$33.68 - $41.95 $341,683 - $425,582	-10,145 Reduced 3.21%	306,339 $12.5 Million
Q4 2023 Jan 29, 2024	BUY	$33.32 - $42.1 $808,076 - $1.02 Million	24,252 Added 8.3%	316,484 $11.7 Million
Q3 2023 Oct 10, 2023	BUY	$36.46 - $44.03 $2.04 Million - $2.46 Million	55,864 Added 23.63%	292,232 $11.2 Million
Q2 2023 Jul 14, 2023	BUY	$30.28 - $38.74 $507,825 - $649,708	16,771 Added 7.64%	236,368 $8.53 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $7.22 Million - $12.2 Million	219,597 New	219,597 $8.39 Million
Q4 2021 Jan 26, 2022	SELL	$31.82 - $40.75 $4.32 Million - $5.53 Million	-135,726 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$38.47 - $46.42 $22,235 - $26,830	578 Added 0.43%	135,726 $5.52 Million
Q2 2021 Aug 05, 2021	BUY	$38.84 - $51.31 $202,939 - $268,094	5,225 Added 4.02%	135,148 $6.14 Million
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $99,841 - $130,014	-2,527 Reduced 1.91%	129,923 $5.42 Million
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $10,349 - $17,491	401 Added 0.3%	132,450 $5.66 Million
Q3 2020 Nov 06, 2020	SELL	$25.74 - $29.63 $1.85 Million - $2.13 Million	-71,771 Reduced 35.21%	132,049 $3.47 Million
Q2 2020 Aug 18, 2020	BUY	$16.25 - $26.81 $165,766 - $273,488	10,201 Added 5.27%	203,820 $5.47 Million
Q1 2020 May 08, 2020	BUY	$13.9 - $21.83 $781,054 - $1.23 Million	56,191 Added 40.89%	193,619 $3.48 Million
Q4 2019 Feb 07, 2020	BUY	$14.93 - $19.53 $1.58 Million - $2.07 Million	105,916 Added 336.11%	137,428 $2.44 Million
Q2 2019 Aug 06, 2019	SELL	$14.75 - $17.26 $7,153 - $8,371	-485 Reduced 1.52%	31,512 $541,000
Q1 2019 May 13, 2019	BUY	$13.94 - $17.58 $446,038 - $562,507	31,997 New	31,997 $515,000

Others Institutions Holding HALO

# of Institutions

488

Shares Held

122M

Call Options Held

208K

Put Options Held

66.3K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.97B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.

Account

Wcm Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History